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ABSTRACT 
 
Introduction: Exposure to airborne natural rubber latex proteins has become an important 
occupational health concern, particularly among healthcare workers. The main purpose of 
this study was to investigate the levels of latex aeroallergens in South African dental 
schools.  
Methods: Area (n=95) and personal (n=369) samples as well as rubber containing gloves 
and dental devices (n=19) were collected in 5 dental schools. The air samples were 
collected at a flow rate of 2.5L/min using polycarbonate (PC) filters. Latex allergens (hev b 
1, hev b 3, hev b 5 and hev b 6.02) were quantified in filters and rubber extracts by a 
capture enzyme immunoassay. Data was analysed using STATA 9 computer software 
(StataCorp, 1984-2007, Texas, USA). Non parametric tests were applied as the data was 
skewed. The data was interpreted as ‘low’ with less than 10ng/m3; ‘moderate’ with levels 
between 10-50ng/m3 and ‘high’ with greater than 50ng/m3. 
Results: Aeroallergen concentrations varied among institutions in our study, ranging from 
1.84 to 46.1ng/m3 for personal and 1.33 to 14.97ng/m3 for area samples. Hev b 6.02 was 
below the detection limit for 86.5% of air samples. This study also found that exposure 
levels differed by departments and job type. Powdered latex products showed higher 
allergen concentrations compared to the non-powdered products (p=0.035) and also 
differed significantly by the type of brands (p=0.022). Hev b 6.02 was the most prominent 
allergen in powdered gloves and dams.  
Conclusion: The air sampling method and capture enzyme immunoassay used in this study 
offer means for evaluation of airborne allergen concentrations. The initiative to use non-
powdered low protein latex gloves and dams should be implemented as a preventive 
measure.  
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PREFACE 
 
Occupational exposure to hazardous biological agents (HBAs) has gained momentum 
recently. Much interest has focused on airborne biological agents (bioaerosols) and the 
health effects it causes to exposed workers. Bioaerosol hazards arise from exposure to 
agents of biological origin which could lead to allergenic reactions, respiratory 
sensitisation and toxicological reactions.  
 
The South African Occupational Health and Safety Act (OHSA), 1993 (Act NO 85 of 
1993) requires the employer to create a safe working environment and without risk to the 
health of workers, as far as reasonably practicable. The OHSA Act includes the regulation 
for HBA’s, in addition to the regulation for hazardous chemical substances (HCS’s). 
 
The National Institute for Occupational Health (NIOH) is an institute within the National 
Health Laboratory Service (NHLS), committed to improving occupational health in South 
Africa and also to supporting the development of occupational health services in the 
neighbouring countries (Southern African Development Community). This is achieved 
through occupational health research, training and specialised services. The findings from 
this study will contribute to a commitment of reducing exposures and hence creating a 
safer environment for HCWs. 
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CHAPTER 1 
 
1.0 INTRODUCTION 
 
Exposure to airborne natural rubber latex (NRL) has lately become a concern worldwide 
and has emerged as the major cause of respiratory diseases among exposed workers, latex 
allergy being one of them. It has also been reported as the fourth most common cause of 
occupational asthma (Heilman et al., 1996; Sussman et al., 1998; Baur et al., 1998; Liss 
and Sussman, 1999; Vandenplas et al., 2002), and first in South Africa (Hnizdo et al., 
2001).  Powdered latex gloves have been identified as a major source of occupational 
exposure to allergens because they contain soluble proteins responsible for sensitisation 
(Lopes et al., 2004). However not all powdered gloves have high allergen content 
presumably due to variations in their production (Hunt et al., 2002). When the gloves are 
snapped on and off, latex proteins bound to the cornstarch powder become airborne and 
may be inhaled and come into contact with body membranes (SORDSA, 1998; De Beer et 
al., 1999; Swanson et al., 2001; Reiter, 2002; Jones et al., 2004, Lopes et al., 2004). A case 
of latex allergy due to airborne latex exposure was first reported in 1990 (De Beer and 
Cilliers, 2001) Although it is well known that glove powder act as a carrier for latex 
allergens, a very limited number of studies of latex allergy have included the evaluation of 
workplace exposures to latex aeroallergens. 
 
Allergy due to NRL has become an important occupational health concern recently.  
Health Care Workers (HCWs) are at increased risk of latex allergy from frequent use of 
disposable latex gloves, particularly those that are powdered and of high protein content 
(Hunt et al., 2002; Swanson et al., 2001). Dentists are considered a high risk-group among 
the clinical specialities due to prolonged usage of latex gloves during working days (Jones 
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et al., 2004).  Most studies have reported prevalence of latex sensitivity in dental schools 
using a questionnaire, skin prick testing (SPT) and serological testing. However not many 
studies have reported on airborne levels of latex allergens in dentistry which contribute to 
sensitisation (Katelaris et al., 1996; Allmers et al., 1998; Saary et al., 2002; Jones et al., 
2004). 
 
The inhalation of allergen particles dispersed in the air is capable of triggering nasal, 
ocular and respiratory symptoms that may lead to rhinitis, conjunctivitis, asthma and 
anaphylaxis in sensitised individuals (Lopes et al., 2004).  Allmers and colleagues reported 
upper and lower respiratory tract symptoms and NRL specific IgE antibodies HCWs 
working in rooms with a detectable latex aeroallergen load (Allmers et al., 1998).   
 
Repeated exposure to natural latex protein resulting in latex allergy is determined by 
factors such as dose, duration and the route of exposure. It is therefore essential to prevent 
or minimise further individual sensitisation by controlling exposure to allergenic proteins 
to ensure safety. The latter cannot be accomplished without accurate and reliable methods 
for quantifying allergens. Efforts to develop these methods have been hindered by limited 
knowledge of the identity of individual allergenic proteins; although there has been 
significant progress in this area recently with more than 16 allergens being identified 
(Tomazic-Jesic and Lucas, 2002). 
 
However, there is currently no standardised method for determining allergenic latex 
proteins mainly because relevant latex allergens are not accurately identified. 
Measurements of these allergens are needed to identify latex products with high levels of 
extractable allergens; and to examine the effects of various interventions to reduce the 
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levels of latex aeroallergens (Hunt et al., 2002).  Total protein measurements currently 
serve as a useful indicator of the exposure of concern.  These include the modified Lowry 
method; amino acid analysis; latex ELISA for antigenic protein (LEAP); ASTM6499 and 
ELISA inhibition assay.  However, these methods are not sensitive or specific enough, and 
are subject to error which may be due to interference with chemicals found in latex 
products, resulting in inconsistent and unreliable results. 
 
The Food and Drug Administration (FDA) has introduced the modified Lowry method 
(ASTM D5712) to measure the total soluble protein content of gloves.  However, the true 
allergen content is not determined by this method because not all proteins are allergenic.  
In addition the procedure is labour intensive and time consuming as it takes a full day to 
analyse 8 –10 samples and cannot identify or quantify specific proteins that may cause 
serious allergic reactions.  The amino acid analysis measures the amino acid content of 
proteins after hydrolysis of hydrochloric acid.  This method is technically demanding and 
requires experienced personnel; cannot differentiate relevant allergens from other proteins 
and requires expensive and advanced equipment.  The LEAP assay and ASTM D6499 use 
serum from rabbits immunised with latex proteins.  This method consists of many steps to 
perform and therefore cannot be standardised; nor do the test results correlate with the 
allergen content of the end product.  The RAST method uses serum from patients 
diagnosed with latex allergy and has shown the difficulty of standardisation due to variable 
antibody reactivity of the patient pool and also the scarcity of latex allergic patients. 
 
Measuring total protein content does not provide reliable information regarding the 
allergenicity of a product as the method cannot differentiate between allergenic and non-
allergenic proteins.  NRL proteins are known to induce immediate type latex allergies, it is 
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therefore necessary to improve methods to measure these sensitising agents quickly and 
accurately. Other conventional methods of measuring the total mass of particulates 
collected on polyvinyl or mixed cellulose ester filter medium are of little value.  Counting 
of particles is also of little value as numerous small latex particles may be attached to large 
particles (Reiter, 2002). 
 
FIT Biotech (Finland, Tampere) has developed the FITkit, a commercial latex allergen 
analyzing tool used to identify four major allergens (individually) out of 13 latex allergens 
listed by the World Health Organisation (WHO). These tests are sensitive and accurate 
immunological tests that can identify individual clinically relevant latex proteins in latex 
gloves. The kit overcomes the significant limitations of previous methods by using highly 
purified and characterised allergens and specific monoclonal antibodies developed against 
four relevant allergens (hev b 1, hev b 3, hev b 5, hev b 6.02). These allergens have been 
demonstrated to resist glove manufacturing processes and have been unequivocally shown 
to be present in medical glove extracts (Palosuo et al., 2002; Palosuo et al., 2007; Poulos et 
al., 2002; Mitakakis et al., 2002). The use of highly purified and characterised allergens 
and monoclonal antibodies enables standardisation and quantification of individual 
allergens. A significant correlation has also been identified between the IgE based method 
and the capture EIA (sum of four allergens) in gloves (Palosuo et al., 2002; Palosuo et al,. 
2007). 
 
These major protein allergens have been categorised as low, moderate and high as shown 
in Table 1.1, based on the correlation of FITkitTM allergens to the true total allergen levels 
measured by the ELISA inhibition test (Palosuo et al., 2002; NAM, 2003; FITkit, 2002). 
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Table 1.1 Allergenicity classifications of latex gloves (NAM, 2003; FITkit, 2002) 
Allergenicity Classifications 
Classification ELISA IgE Inhibition Sum of Hev b 1 , Hev b 3, 
Hev b 5, Hev b 6.02 
Low <10AU/ml ≤ 1µg/g 
Moderate 10-100AU/ml 1-5 µg/g 
High >100AU/ml >5µg/g 
 
Hev b 5 and hev b 6.02 are considered the most important allergens for HCWs (Palosuo, 
2002, Palosuo et al., 2007).  Hev b 1 and hev b 3 have been reported in spina bifida. 
Adding to the list, Bernstein et al (2003) described hev b 13 (43kDa) as another relevant 
allergen among HCWs using SPT.  Lee et al (2006) also identified a 30kDa, hevamine 
(hev b 14, at least 50% according to WHO/IUIS), a candidate for a major H. brasiliensis 
allergen as a predominant protein in the latex gloves used by medical workers in Taiwan.  
 
Research on allergenic proteins in rubber gloves has been done for a long time but the 
means to measure clinically relevant allergens have been lacking until recently. The 
capture ELISA assay allows manufacturers and authorities to measure allergen levels in 
gloves and thus provide a means of measuring allergenicity for safer use of latex gloves 
among HCWs.  However it has not been applied to measure airborne latex allergens.  
Airborne latex allergens are unavoidable, thus making it difficult to control exposure or 
prevent inhalation of these allergens.  Thus far only a few publications have reported the 
measurement of latex allergens in glove powder and in airborne particulates (Baur, 2002; 
Kujala et al., 2002).  There have been no reports on measuring the levels of latex allergens 
in the environment in South Africa, thus more detailed research is needed to establish these 
methods for workplace evaluations and assessments of risks of exposure locally.   
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For the purpose of this study enzyme immunoassay (FITkit Biotech, Tampere, Finland) 
will be adapted for determining the levels of clinically relevant latex allergens in air 
samples collected from various dental institutions.  It has been selected as the method of 
choice due to its suitability that allows for the direct measurement of relevant individual 
allergens and short assay time (~2 hours) when compared to other methods. The assay is 
currently available only for research purposes as stated on the kit’s inserts, therefore  a 
promising ELISA assay for latex allergen quantification using monoclonal antibodies. 
 
The purpose of this study was to investigate the levels of airborne latex allergens in work 
areas of five dental schools of South Africa. 
The main objectives of this study are:  
o To validate the FITkit and establish a reliable technique at the National Institute for 
Occupational Health (NIOH) for detecting latex aeroallergens from air samples 
collected in dental schools. 
o To identify the type of latex products used in dental schools which may be 
contributing to aerosols in dental schools. 
o To estimate the total protein content and measure the total allergen content (sum of 
hev b 1, hev b 3, hev b 5, hev b 6.02) in latex products e.g. gloves and  rubber dams 
used in  South African dental schools. 
o To detect and measure the levels of latex aeroallergen in various dental work areas. 
 
These objectives were addressed in this study and are highlighted in three sections of this 
dissertation; chapter 3 which will cover materials and methods, chapter 4 which will cover 
the results and chapter 5 which will be the discussion and conclusion. 
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CHAPTER 2 
 
2.0 LITERATURE REVIEW 
 
2.1 Natural Rubber Latex  
 
Natural rubber latex (NRL) comes from the milky sap derived from a rubber plant known 
as Hevea brasiliensis found predominantly in South East Asia (Fish, 2002; Mc Fadden, 
2002).  The constituents of latex are proteins, lipids, nucleotides and cofactors (De Beer et 
al., 1999).  The use of latex dates back to as early as 1600 BC; however, its use in the 
medical setting was only adopted by surgeons between 1890 and 1910.  Currently, NRL is 
widely used in the workplace and plays an important role in providing effective barrier 
protection against transmission of bloodborne pathogens and other infectious agents such 
as the human immunodeficiency virus (HIV) and Hepatitis B for HCWs (De Beer et al., 
1999; Mc Fadden, 2002).  Because of its unique advantages in elasticity, flexibility, barrier 
properties, comfort and cost effectiveness, latex is still chosen over synthetic polymers 
(e.g. polyvinyl chloride and nitrile) as essential for accomplishing barrier protection 
(Charous, 1998; Mc Fadden, 2002). 
 
This increased demand for latex gloves brought about changes in the processing and 
manufacturing of gloves, which have resulted in poor quality and highly allergenic 
products.  Changes in manufacturing include short washing processes and shelf lives, 
which increased the amount of extractable latex protein antigens in gloves associated with 
the increase in prevalence and exposure to latex (De Beer et al., 1999). NRL is a 
component of various medical devices and domestic products and is used for protective 
and hygiene purposes (Koh et al., 2005). Besides the healthcare settings, latex products 
including gloves are commonly used in other industries such as food and beverage, 
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manufacturing, and glove factories (Heilman et al., 1996; Poulos et al., 2002; Swanson et 
al., 1994, Koh et al., 2005). The growing use of NRL products, particularly in the health 
profession has led to the unfortunate trade-off between protection offered by these gloves 
and adverse reactions associated with an increase in allergic diseases and contact dermatitis 
from rubber additives related to the use of these devices (Saary et al., 2002).  Latex gloves 
have therefore introduced health hazards associated with the use thereof (Wrangsjo et al., 
2001). 
 
2.1.1 Latex allergens for Hevea Brasiliensis 
Latex allergens are proteins found in latex products and on powders present in latex 
products in the form of aeroallergen particles (Reiter, 2002).  Healthcare settings using 
powdered gloves are likely to have a measurable concentration of latex allergens in the air 
(Swanson et al., 2001)  and represent a health hazard to healthcare workers who are 
inadvertently exposed to them on a regular basis (Potter et al., 2001).   
 
Latex allergen settles rapidly from the air and very little, if any, airborne latex allergens 
remain in an unused room after 24 hours (Hunt et al., 2002), until resuspended by 
movement.  Latex allergens may be present in the air as individual particles or may adhere 
to the surface of other particulates (Reiter, 2002).  Natural rubber proteins from latex are 
allergenic (Swanson et al., 1994) and commonly found in medical and dental office 
buildings (Swanson and Ramalingam, 2002).  It is not the powder that the person becomes 
allergic to, rather the protein sticking to the powder (Amr and Bollinger, 2004).   
 
Research efforts have resulted in identification of several purified latex allergens.  The 
World Health Organization and the International Union of Immunological Societies 
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(WHO/IUIS) now lists 13 NRL allergens characterised at the molecular level (Rihs and 
Raulf-Heimsoth, 2003; Bernstein et al., 2003; Yeang, 2004; Wagner and Breiteneder, 
2005). Eight of these allergens have been reported to be the most significant latex allergens 
because they are the allergenic proteins that yield the highest prevalence of IgE 
specificities from serum and by skin prick test (Yeang et al., 2006). Table 2.1 shows an 
overview of the current status of characterised NRL allergens with their immunological 
and clinical properties. 
 
2.1.2 Sampling for latex aeroallergens  
 
Sampling for airborne allergens in the occupational setting usually involves collection of 
airborne dust on filters using pumps. Sampling can either be static (area) or personal 
(breathing zone) depending on the needs of the individuals. Collection of inhalable dust 
using personal sampling pumps has clear relevance to personal exposure compared to static 
sampling. Several methods have been developed to assess exposure to protein allergens, 
both enabling and necessitating a choice between different methods (Renstrom, 2002).  
 
The sampling method used for latex aeroallergens must be capable of collecting submicron 
sized particles efficiently on a medium from which the allergens can be extracted 
completely. The volume of air sampled must be adequate to provide enough allergens for 
precision analysis with sensitivity in the nanogram per cubic meter (ng/m3) range. The 
recommended flow rate is 180L/ for 2 to 4 hours min (21 600 to 43 200 L) using a high 
volume sampler and polytetrafluoroethylene (PTFE) filter. Latex allergen sampling can 
also be achieved by surface sampling using either wipe sampling or surface vacuuming. 
The technique indicates the presence and absence of latex allergens (qualitative) and may 
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also be semi quantitative by indicating the levels of latex allergen per square surface area. 
The results are expressed as detected versus undetected; nanogram per sample; nanogram 
per gram of dust or nanogram per square surface area. The shortfall of these techniques is 
inconsistency in wiping efficiency and possibility of filter media destruction during 
sampling (Reiter, 2002). 
 
Swanson et al (1994) used area samplers and personal breathing zone samplers to collect 
air samples from various areas in the medical centre. Area samplers were operated at a 
flow rate of 3L/sec for 4 hours and personal samplers at a flow rate of 5L/min (Swanson et 
al., 1994; Poulos et al., 2002; Hunt et al., 2002). A portable vacuum with PTFE filter 
connected to the hose was used to collect particles from used laboratory coats and surgical 
suits at a flow rate of 1L/sec for 1 hour. Air particles were collected onto PTFE filters. 
Airborne allergen concentrations for area samples varied from 13 to 121ng/m3 while for 
personal samples varied from 8 to 978ng/m3 in areas where latex gloves were frequently 
used (Swanson et al., 1994).  Using the same flow rates as Swanson et al (1994), a cross 
sectional study done at the Mayo medical centre (Rochester, Minnesota) reported latex 
aeroallergen levels ranging from 13 to 208ng/m3 in 11 areas using powdered latex gloves 
and levels between 0.3 to 1.8ng/m3 in 4 areas where powder free or synthetic gloves were 
used (Hunt et al., 2002). 
 
In a Canadian epidemiological study, 12 personal and 8 area samples were collected in 
different wards and operating rooms during use of powdered gloves. The number of pairs 
of gloves used during the day of sampling ranged from 3-14. Latex aeroallergen were 
quantified using indirect ELISA method and personal exposure ranged from 5-616µg/m3 
(Sri-akajunt et al., 2000). 
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A study by Page et al (2000) collected area air samples using 2 high volume samplers 
operated at 5.7L/sec and 6.1L/sec. The sampling time was 8 hours and 17 minutes. Latex 
particles were collected on bilaminate glass fibre and PTFE membrane filters.  The 
concentrations of latex ranged from non-detected to 3.33ng/m3 with geometric mean 
concentration of 0.52ng/m3. 
 
Swanson and co-workers (2001) have collected air particles onto PTFE filters by a 
volumetric filtration method using a static air sampler at a flow rate  of 3l/sec. The NRL 
allergens were extracted from filter samples in PBS and quantified by an immunoassay 
using pooled sera containing latex specific human IgE. The concentrations of latex 
allergens during working hours in areas where latex gloves were frequently used ranged 
from 5 to 26ng/m3. The highest concentration of latex allergen (26ng/m3) was found in a 
gynaecology examination room. Areas that seldomly used latex or powder free gloves 
demonstrated concentrations below the detection limit of less than 5ng/m3.  Data was 
interpreted as: low (less than 10ng/m3); moderate 10-50ng/m3; and high greater than 
50ng/m3. It was found that the levels of latex allergens captured were dependent on the 
number of gloves used (Swanson et al., 2001). 
 
Baur (2002) collected airborne latex particles using two different types of area samplers 
operated for 20 hours with cellulose membrane filters.  The VC 25 area sampler was 
operated at a flow rate of 22.5m3/h for rooms larger than 200m3 and WAZAU area sampler 
at a flow rate of 2.8m3/h for rooms smaller than 200m3. The concentration of latex 
aeroallergen ranged from less than 0.4 to 240ng/m3 (Baur, 2002). 
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Another study was done in ambulances to quantify concentrations of NRL bioaerosols.  
Latex allergens were captured on 0.3µm PTFE filters with an area sampler operated at a 
flow rate of 2.5L/s for 1hour.  Personal air sampling pumps were worn by paramedics 
during their work shift inside the ambulance at a flow rate of 3L/min for 5 to 6 hours. The 
detection limit was approximately 1ng/m3 for area samples and 5ng/m3 for personal 
samples, the differences related to collection volumes.  The latex aeroallergen levels in so-
called latex-free ambulances were undetectable with an area air sampler.  The results from 
the study have shown that ambulances where powdered latex gloves are used, show 
moderate (10-50ng/m3), high (>50ng/m3) and even very high latex aeroallergen 
concentrations.  The recommendation made was that by using powder free latex gloves and 
cleaning vehicle surfaces thoroughly, latex allergen concentrations can be decreased to 
acceptable levels (Quirce et al., 2004). 
 
Air sampling for latex allergens differs between laboratories, therefore the suitability and 
shortcomings should be taken into consideration when planning the sampling strategy. 
Some factors have to be considered when sampling the dental population and this includes: 
short sampling times due to the type of procedures (clinic sessions that last a maximum of 
2 hours 30 minutes), variety of work, effort to minimise disruption between patient and 
dental staff performing the procedure, ensuring well serviced pumps are used to reduce the 
noise levels and pumps that are cumbersome to wear in the presence of patients.  
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Table 2.1 Overview of characterised NRL allergens and their significance.  
Latex 
allergen 
Molecular 
mass 
Protein name Significance as latex allergen Is recombinant   
protein available? 
Hev b 1 14.6 Rubber elongation factor (REF) High, (spina bifida (SB) patients Yes 
Hev b2 34-36 ß-1,3-glucanase Medium Yes 
Hev b3 24-27 Small rubber particle protein High (SB patients) Yes 
Hev b4 50-57 Beta-glucosidase (microhelix component ) Not determined No 
Hev b5 16-24 Acidic structural protein High-all risk groups. HCW, SB, atopics Yes 
Hev b6.01 20 Prohevein (hevein precursor) High-all risk groups. HCW, SB, atopics Yes 
Hev b6.02 4.7 Hevein  High-all risk groups. HCW, SB, atopics Yes 
Hev b6.03 14 C-domaine of prohevein High in context with Hev b6.01 Yes 
Hev b7.01 42 Patatin-like protein (esterase) from latex B- serum Low-medium Yes 
Hev b7.02 44 Patatin-like protein (esterase) from latex C- serum Medium only in SB Yes 
Hev b8 14 Profilin (actin-binding protein Low Yes 
Hev b9 51 Enolase Low Yes 
Hev b10 26 Manganese superoxide dismutase (MnSOD) Low Yes 
Hev b11 32 Class I chitinase Low Yes 
Hev b12 9 Lipid transfer protein Low Yes 
Hev b13 42 Esterase High Yes 
Rihs&Raulf-Heimsoth, 2003; Yeang, 2004; Wagner&Breiteneder, 2005 
2.2 Prevalence of latex allergy caused by NRL 
NRL is a natural product and, like other plant based material, it has the potential for 
sensitisation (Kalman, 2005).  Allergy due to NRL has become an important occupational 
health concern particularly among healthcare workers and the source of workplace exposure is 
the use of powdered latex gloves (Liss and Tarlo, 2001).  Most studies have reported an 
increased prevalence of latex allergy internationally but this has not been widely documented 
in South Africa (Brathwaite et al., 2001).   
 
Currently, latex allergy is recognised as a serious worldwide health problem with 5-17% 
prevalence in HCWs (depending on the occupational group and country of origin), 1-6% in the 
general population; and 8.8-13% of dentists being allergic to latex. A high rate of sensitisation 
to NRL has been documented in dental students and staff members in Ontario, Canada and the 
prevalence was found to be 10 % in a total sample size of 131, with students developing 
sensitivity as early as the second year of substantial glove use, that is third year students (Tarlo 
et al., 1997; Saary et al., 2002).  There have been increasing percentages of positive skin tests 
to latex with increasing years of study among the students, 0% of first and second year; 6% 
third year and 10% of fourth year students (Tarlo et al., 1997).   Thirty nine of 226 (17.3%) 
dental students had a positive skin prick test to at least 1 of the 6 latex substances tested 
(Schmid et al., 2002). 
 
Previous research indicated that latex allergy is a problem in South African hospitals 
(Pretorius et al., 2001) with Potter et al (2001) reporting a prevalence of 9-20% of latex 
sensitivity in three South African hospitals using powdered latex gloves.  
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South Africa’s first case of latex allergy was diagnosed in 1993 in a nursing sister at Groote 
Schuur hospital in Cape Town and this led to a survey, which identified 23 more cases of latex 
allergy.  This study showed the possibility that latex allergy problem may be widespread in 
South Africa (De Beer et al., 1999; Potter et al., 2001).  
 
Several other studies have been done in South Africa: one in the Red Cross War Memorial 
Children’s Hospital (RXH) and the other at Groote Schuur hospital.  Latex allergy was found 
to be a significant occupational health risk at RXH, with 48.5% (146/302) staff (medical, 
nursing and auxiliary) showing one or more allergic symptoms and 7% (10/142) positive for 
IgE mediated hypersensitivity to latex (Braithwaite et al., 2001).  The prevalence of 
symptomatic sensitisation to latex among all hospital workers was found to be between 9.2% 
and 11.2% at Groote Schuur hospital.  At Tygerberg, also in the Cape, 20.8% of a high risk 
group of HCWs (ICU and operating theatres) were also found to be latex sensitive (Potter et 
al., 2001).   
 
Another small study was conducted among 146 laboratory workers at the South African 
Institute for Medical Research (SAIMR), now the branch of the National Health Laboratory 
services (NHLS) in Johannesburg using CAP RAST test and a prevalence of 2.7% was 
reported (Potter et al., 2001).  In 2002, the National Centre for Occupational Health (NCOH), 
now the NIOH, conducted a small study on latex allergy at the Johannesburg Hospital (NJH) 
where employees were tested using the UNICAP and skin prick tests.  The results from this 
study have shown a prevalence of 28.2% (22/78) IgE mediated hypersensitivity (Z. Kirsten, 
personal communication, 2006). An epidemiological study done recently in South Africa at 
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Pretoria academic hospital and Medforum reported 38.2% dermatological reactions to latex 
among participating nursing healthcare professionals (Pretorius et al., 2001).   
 
2.3 Risk groups from exposure to latex allergens 
Latex gloves are commonly used in various occupations including manufacturing and 
healthcare (Swanson et al., 1994; Heilman et al., 1996; Poulos et al., 2002) and are regarded as 
the most common source of latex exposure (Lindberg and Silverdahl, 2000; Jones et al., 2004).  
In addition to hand eczema and acrylate allergy, latex allergy has been an occupational health 
issue in the dental profession as in other fields of heath care (Lindberg and Silverdahl, 2000; 
Saary et al., 2002).  Type 1 sensitivity to natural rubber latex has been recognised more 
frequently among healthcare workers, including physicians and dentists (Hunt et al., 1995).  It 
has been demonstrated that dental students with increasing exposure to latex have an 
increasing incidence of latex allergy (Saary, 2002).  Studies have indicated that atopics have 
an increased risk of sensitisation to workplace allergens, particularly high molecular weight 
agents like latex (Poulos et al., 2002; Petsonk, 2002). 
 
Healthcare workers are at risk of latex allergy from frequent use of disposable latex gloves, 
particularly those that are powdered and of high protein content (Hunt et al., 2002).  Among 
this group, dentists are considered a high risk-group due to prolonged usage of latex gloves 
during working days (Jones et al., 2004).  Due to the high latex component of many products 
associated with dental practice (e.g. dental dams, suction tubing and impression casts) many 
dental practitioners had to quit their profession due to the development of latex allergy from 
the wearing of gloves (Jones et al., 2004).  Although many latex allergic people are able to 
continue practising by switching to non-latex gloves, others develop severe allergic responses 
such as asthma and anaphylaxis such that they are forced to change their careers (Saary et al., 
2002).  Up to 40 % of dental personnel reported dermatological reactions due to latex gloves. 
Studies have reported that dental students using powder free gloves have shown no 
sensitisation while 5-15% of those using powdered gloves were sensitised (Liss & Tarlo, 
2001; Allmers et al., 2004).  The general population is also exposed to latex with the use of 
natural rubber products in normal life (Crippa et al., 2006). Other distinct groups that are at 
risk include rubber plantation workers, glove manufacturing (Sri-Akajunt et al., 2000), 
hairdressers (Crippa et al., 2006), housekeeping personnel (Koh et al., 2005) and food 
processors.  
 
A recent study conducted in South Africa by Lopata et al (2007) demonstrated severe 
occupational sensitisation to latex among workers in the textile industry. Occupational asthma 
was caused by excessive dust originating from elastic material, not initially suspected to 
contain latex, utilising specialised allergological testing. This is one of few international 
studies to demonstrate sensitising latex allergens in material other than gloves. 
 
Furthermore, latex sensitisation was also demonstrated among seafood processing workers in 
the Western Cape, and the significance of non-specific carbohydrate determinants is 
highlighted too, relevant for correct diagnosis (Raulf-Heimsoth, In press). 
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2.4 Sources of exposure to latex allergens 
Exposure routes to latex proteins vary from skin contact by wearing latex gloves to inhalation 
of latex protein bound to glove powder that becomes airborne (De Beer, 1999).  Studies have 
shown that high concentrations of latex aeroallergen have been found in areas where large 
numbers of gloves are routinely donned and discarded, and increased latex aeroallergen 
exposure using personal breathing zone sampling has also been documented (Hunt et al., 
1995; Heilman et al., 1996; Vandenplas et al., 1996; Poulos et al., 2002).  
 
The cornstarch powder used to coat gloves poses a serious threat because proteins bind to the 
powder and become aerosolised and inhaled (De Beer et al., 1999).  Aerosolised glove powder 
is the most common source of latex protein inhalation (Heilman et al., 1996).  This powder or 
bioaerosols feature as a carrier for natural rubber latex aeroallergen (Swanson and 
Ramalingam, 2002). Heilman et al (1996) suggested that aeroallergen levels found by air 
sampling on high allergen glove days were associated with the number of high allergen gloves 
used and not with the total number of gloves used on low allergen days. In contrast, a study 
done in air samples from different areas at the Mayo clinic has shown that the amount of latex 
allergen measured correlated with the frequency of glove use and glove changes (Poley and 
Slater, 2000).  
 
The amounts of latex proteins carried by glove powder are sufficient to generate levels of 
aeroallergen capable of triggering allergic reactions, thus promoting atopic sensitisation 
indirectly (Charous, 1998).  Allergen carried on the powder is not the only source of exposure.  
The high levels of aeroallergen were reported at a plant producing chlorinated gloves during 
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the outstripping process when no workers were present. The concentrations of airborne 
allergen in many areas of glove manufacturing plants where workers are present are similar to 
those in medical care facilities where the levels are high (Hunt et al., 2002).  Aeroallergens 
have also been reported in plantations when the sap is being harvested from rubber trees (Sri-
akajunt et al., 2000). 
 
Not all airborne latex allergens arise from gloves (Hunt et al., 2002).  Although the risk of 
exposure is greatest during donning or removal of gloves, another concern regarding airborne 
latex allergens is that the particles may also be deposited throughout the environment. These 
particles may be resuspended from surfaces e.g. surgical suits, coats or other clothing, 
furniture (Swanson et al., 2001; Poulos et al., 2002; Hunt et al., 2002) by human activity, air 
movement or ventilation, creating a secondary source of exposure causing respiratory diseases 
when inhaled (Reiter, 2002).  Previous research has revealed that avoiding direct contact with 
latex gloves was not enough to reduce sensitisation in allergic individuals when other workers 
use powdered latex gloves in the same enclosed environment (Hunt et al., 1995; Vandenplas et 
al., 2002; Beezhold, 1996; Poulos et al., 2002; Mitakakis et al., 2002; Lopes et al., 2004). 
 
 
2.5 Health effects associated with latex aeroallergens 
Several studies have shown that inhalation of latex aeroallergens carried on cornstarch powder 
of latex gloves causes cutaneous, conjunctival and/or respiratory responses to latex. Studies by 
Tarlo and colleagues were among the first to suggest that rhinoconjuctivitis and asthma were 
caused by airborne cornstarch particles bearing latex allergens (Fish, 2002). Symptoms 
associated with exposure to aerosolised NRL reactions include urticaria, rhinitis, hoarseness, 
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wheezing, shortness of breath, conjunctivitis, chest tightness, asthma and life threatening 
anaphylaxis.  Other indications of latex allergy include sneezing and a runny nose.  Many 
other workers have also reported eye symptoms that appeared to be associated with 
aerosolised allergen (Liss and Sussman, 1999; Vandenplas et al., 1996; Hunt et al., 1995; Fish, 
2002; Mitakakis et al., 2002; Swanson et al., 2001; Liss and Tarlo, 2001; Swanson and 
Ramalingam, 2002; Reiter, 2002). 
 
Asthma due to latex may result from indirect exposure to airborne latex in medical settings 
and latex proteins are believed to be the potent causative agents (Vandenplas et al., 1996).  
Latex has become one of the main causative agents of occupational asthma (Baur, 2002) and 
was the most frequently reported agent by SORDSA between 1996 and 1998 (Hnizdo et al., 
2001). The route of particles from ambient air into the lower respiratory tract is complicated. 
In general, particles <5µm diameter can penetrate the lungs while those >10µm are unable to 
penetrate below the glottis. Thus the nose and the eyes have greater exposure to airborne 
allergens than the lungs (Fish, 2002). 
 
2.6 Recommended Occupational Exposure Limits (OEL) 
Exposure limits can be defined as the levels that can be expected to cause allergic reactions in 
individuals who are exposed to a particular allergen (Poley and Slater, 2000).  The safe 
occupational exposure limits for latex allergens causing sensitisation and symptom 
provocation are currently not documented and comparison of sample results with the OEL to 
interpret data is therefore impossible (Reiter, 2002; Baur, 1998; Heilman et al., 1996). Since 
methods for sampling and analysis of airborne allergens vary between laboratories, 
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determining the occupational exposure limits is not feasible and general standardised methods 
are needed. 
 
Presently, exposure criteria for latex allergens are based on research and toxicological data 
(Reiter, 2002) by measuring the concentration of allergens in the work area and comparing 
this with symptoms (Hunt et al., 2002). This approach makes the interpretation more difficult 
and no conclusion can be drawn about exposure (Reiter, 2002).  NRL is a mixture of potent 
allergens of which each has different stability and bioavailability characteristics and is likely 
to occur at different levels in various environments depending on the source of exposure.  An 
average of exposure limit values may mask biologically significant specific allergen limits 
(Poley and Slater, 2000). 
 
Two approaches have been adopted in an attempt to determine how much airborne allergen is 
required to cause respiratory symptoms and what permissible exposure limits should be for 
NRL.  The first approach is to measure the levels in the work area and compare it with 
symptoms. Using this approach it was estimated that a few symptoms occurred at levels below 
10ng/m3 (Hunt et al., 2002).  Several other studies demonstrated that latex levels of 0.6ng/m3 
or greater induced occupational respiratory responses (e.g. conjunctivitis, rhinitis and asthma) 
and the development of latex specific antibodies (Baur, 1998; Swanson and Ramalingam, 
2002).  This figure is 100 to 1000 fold less than the levels measured in areas where latex 
gloves are routinely used, suggesting that avoidance of aeroallergen exposure is the only way 
to prevent latex allergy in the workplace (Poley and Slater, 2000).  
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The second approach was to challenge patients under controlled exposure conditions which 
indicated that a higher value of 100 to greater than 1000ng/m3 is required to provoke mild 
reactions (Hunt et al., 2002). An industrial hygiene study reported air sample results exceeding 
50ng/m3 as having a high risk potential for triggering allergic reactions; 10-50 ng/m3 with 
moderate risk potential particularly to atopics and less than 10ng/m3 have shown low risk of 
allergic reaction depending on an individual’s immune system (Reiter, 2002; Hunt et al., 
2002).  These values refer to the risk of exposure by skin contact but can also be used to 
evaluate surface or dust samples (Reiter, 2002).   
 
Researchers who determined the levels of allergen using immunoassays concluded that lower 
allergen levels were necessary to induce symptoms than researchers who measured the dust 
content and have set higher limits of allergen detection in the dust. OELs do not provide 
information on the incremental degree of sensitisation that occurs with increasing exposure 
and/or the reduction in sensitisation and reaction rates associated with a decrease in exposure 
(Poley and Slater, 2000).  Starch powder is regarded as a carrier for NRL aeroallergen and the 
FDA proposed a limit of 120 mg of powder per glove.  The FDA did not choose elimination of 
powdered gloves but preferred to limit the protein content of gloves and the powder mass 
(Swanson and Ramalingam, 2002). Previous studies have reported a decrease in number of 
cases of latex induced occupational asthma in Ontario, Canada eith the use gloves with 
reduced powder and/or protein (Allmers et al., 2004). 
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2.7 Legal implications of latex allergy  
In South Africa, the rights of employees are protected by the Occupational Health and Safety 
Act (No 85 of 1993) under which the employer is obliged to provide a safe working 
environment as far as reasonably practical, and without risk to the health of workers (Potter et 
al., 2001; Pretorius et al., 2001).  If powdered gloves are worn, latex allergens may be airborne 
and inhaled, thus representing a health hazard (Potter, 1998).  
 
Sensitisation of workers to latex may involve many high costs which includes workers’ 
compensation (Horwitz and Kammeyer-Mueller, 2002).  Natural rubber latex is legally a 
substance hazardous to health under regulation 7 of Control of Substance Hazardous to Health 
(COSHH) Regulations 2002 in the United Kingdom, and exposure must be prevented or 
adequately controlled (Kalman, 2005). 
 
2.8 Recommendations for controlling exposure to latex aeroallergens 
Latex allergic diseases due to exposure to airborne latex allergens are a recognisable problem 
not only for exposed workers but also for the general population.  Preventive measures are 
required to limit the number of new cases of latex sensitivity and avoid clinical manifestations 
in previously sensitised people. 
 
Avoidance of exposure to latex allergens is difficult to implement as the allergens are readily 
distributed via their binding onto cornstarch powder (Vandenplas et al., 2002). However, a 
recent longitudinal study has shown a decreased prevalence of work-related symptoms in 
HCWs in 5 years after a recommendation to avoid natural rubber latex in 2000.  This was 
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achieved using skin prick testing and latex specific Immunoglobulin E. Despite avoidance and 
reduced symptoms, the study also found out that most HCWs continue to retain percutaneous 
reactivity to non-ammoniated latex (NAL). This finding confirms that avoidance of NRL 
decreases but does not eliminate in vivo sensitisation to NAL (Smith et al., 2007). 
 
 
Studies have demonstrated that powdered gloves contain more proteins than non-powdered 
gloves and therefore pose a risk factor by dispersing antigenic proteins into the work 
environment (Lopes et al., 2004). Several studies involving latex sensitive healthcare workers 
suggest that symptoms can be reduced with environmental modification, which involves 
removal of powdered latex gloves from the environment to prevent symptoms from latex 
aeroallergen (Hunt et al., 2002; Reiter, 2002; Mc Fadden, 2002). 
 
Results from a few studies have suggested that the use of low protein, non-powdered latex 
examination gloves are effective in reducing the release of airborne protein levels (Heilman et 
al., 1996; Charous, 1998; Swanson et al., 2001; Schmid et al., 2002; Vandenplas et al., 2002), 
thus leading to a decrease of sensitisation and asthma in those persons not already sensitised to 
NRL (Liss and Tarlo, 2001; Wrangsjo et al., 2001; Saary et al., 2002; Jones et al., 2004). 
Vandenplas et al (2002) reported an improvement in asthma and rhinitis symptoms and 
nonspecific bronchial hyperresponsiveness in the subjects who minimised their exposure to 
latex. Tarlo et al (1994) demonstrated that a latex sensitive laboratory technician had no 
symptoms when co-workers changed from powdered latex gloves to powder free gloves and 
latex aeroallergen levels were not detectable without any other environmental modification 
(Hunt et al., 2002). 
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 Personal use of non-latex gloves has been associated with a decrease in sensitisation and 
serum specific IgE levels; however this has shown not to be sufficient to prevent inhalation of 
latex antigens and the development of asthma if a co-worker continued to use powdered latex 
gloves (Vandenplas et al., 2002).  Another study indicated a decrease of aeroallergen levels 
from up to 49.9ng/m3 to below the detection limit within 24 hours in areas using synthetic or 
powder free latex gloves after replacing powdered NRL gloves.  This demonstrated that 
removal of the source reduced the aeroallergen levels below the detection limit thus 
decreasing the risk of NRL sensitisation and permitting sensitised personnel to remain in their 
careers (Allmers et al., 1998). 
 
The most effective way to manage sensitisation in workplaces is to adopt a glove selection 
policy for South Africa as it has been recommended internationally (UK, Canada, Germany 
and Scandinavia) and by Potter (Potter, 2001).  Although the investment in adopting a latex 
free environment may be initially costly, the long-term savings such as loss of staff and 
productivity, the legal and financial implications for employers and healthcare institutions far 
outweigh the short-term benefit of purchasing cheap products of low quality (Charous, 1998; 
Potter et al., 2001; Lopes et al., 2004).   
 
Other control measures include engineering controls that reduce the amount of latex allergen 
that becomes airborne.  Such controls include the installation of local exhaust ventilation 
systems.  Common industrial measures that are more applicable to industry than in healthcare 
are installation and use of automated systems, construction of enclosures and latex glove 
manufacturing refinements. Use of personal protective equipment (PPE) such as skin and 
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respiratory protection has been recommended as a control measure in industry where NRL is 
used.  Remediation is another method to minimize latex allergen particulates. Remediation 
includes vacuuming surfaces that may contain latex particles with a high efficiency particulate 
air (HEPA) filtered vacuum and wet wiping using isopropyl alcohol as a wiping agent.  The 
success of remediation was illustrated in a latex free dental office and a hospital administration 
office, which had led to sensitisation of workers.  Air and surface sampling results following 
remediation was conducted indicating that the concentrations were below the level of 
detection (Reiter, 2002).  
 
Interventions that involved education programmes, establishment of latex committees, 
surveillance and changes in gloves were implemented at different times in various hospitals in 
Ontario, Canada (Liss and Tarlo, 2001).  Banning of powdered latex gloves in the workplace 
and substitution with latex free material seems to be a sufficient prevention strategy for latex 
sensitisation (Allmer et al., 1998).  In addition to this measure, workers who complain of 
dermal or respiratory symptoms that are strongly linked with the use of latex gloves should be 
provided non latex gloves such as vinyl and synthetic surgical gloves (Lopes et al., 2004). 
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CHAPTER 3 
 
 
3.0 MATERIALS AND METHODS 
 
3.1. STUDY DESIGN 
 
This was a cross sectional (descriptive) study investigating the levels of latex aeroallergens in 
dental schools situated in various provinces. 
 
3.2 SAMPLING POPULATION 
The study workplaces were five dental schools from various provinces which included the 
Universities of Kwa-Zulu Natal (Kwa-Zulu Natal), the Western Cape (Western Cape), 
Limpopo-MEDUNSA campus (North West), Pretoria and Witwatersrand (Gauteng).  The 
study was voluntary and was presented to dental staff and students working at various 
institutions. The study was approved by the ethics committee of the University of the 
Witwatersrand as described in 3.5.6. Interested participants completed a consent form. The 
study participants included dental staff (clinical, administration, laboratory and auxiliary) and 
dental students (excludes first years who are not working in the clinics). The study participants 
were asked to wear a sampling pump for the duration of one clinic session.    
 
3.3 BUILDING INSPECTION 
A walk-through inspection was performed by a qualified occupational hygienist at each dental 
institution prior to sampling.  The aim was to identify the type of gloves used, storage 
facilities, disposal procedures, house keeping; and to obtain information on control measures 
in place by direct observation.  
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3.4 SAMPLE COLLECTION 
 
3.4.1 Area sampling 
Air samples were collected by an Occupational Hygienist (Occupational Hygiene Section, 
National Institute for Occupational Health) and a trained technician in the clinics. Two types 
of air sampling pumps were used due to a large number of samples being collected over a 
short sampling period (two weeks on average). These pumps function the same and will 
therefore have no negative effect on the sampling procedure. The Gillian (SKC Ltd, USA) or 
Casella Apex (Casella, USA) battery operated air sampling pumps were used to collect 
airborne particles in work areas of various dental clinics.  Airborne particles were collected on 
0.4µm, 37 mm sterile polycarbonate (PC) filters at a flow rate of 2.5l/min for approximately 6 
hours. This method has been adapted from Quirce et al., 2004 and was slightly modified by 
replacing the PTFE filters with PC filters and by adjusting the flow rate from 2L/min to 
2.5L/min. Prior to application, both filters were validated in the laboratory under the same 
conditions and they yielded similar results. The PC filter was chosen because it was used in 
another study which took place simultaneously with this study, therefore minimizing the costs. 
Quirce et al (2004) used this method for personal sampling for 5-6 hours. Due to the 
unavailability of high volume area air samplers, the latter method was adapted for area 
sampling in our study for ~6hours. A total of 95 area samples for all five institutions were 
collected in areas where latex gloves were commonly used as well as in areas presumed to be 
unexposed (administration).  After sampling, the filters were sealed and stored in zipped 
plastic bags until analysis at the National Institute for Occupational Health (NIOH) 
laboratories.  
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Environmental parameters such as relative humidity (RH) and temperature that may influence 
the findings were also monitored during the sampling period. Calibration of pumps was 
performed daily before and after sampling using a Gillibrator bubble flow meter (Gillian 
Instrument Corp., Wayne, N). The flow rate of pumps was checked before and after sampling 
to determine the stability of the flow rate over the sampling period. Using the flow rate and the 
sampling time, the volume of the air sampled was calculated. . The concentration of latex 
allergens was obtained by dividing the measured concentration (µg/L) in air filters extracts 
with the sampled air volume; the final aeroallergen concentration was expressed as ng/m3. 
 
3.4.2 Personal sampling 
For personal sampling, air sampling pumps were attached to sampling belts which were worn 
around the waist of the participants.  Airborne particles were collected on 0.4µm, 37 mm 
preloaded sterile polycarbonate (PC) filters at a flow rate of 2.5l/min on the breathing of 
participants breathing zone during one clinic session.  Sampling times ranged from 1 h to 3 
hours depending on duration of the dental procedure or session.  A total of 369 personal 
samples were collected in all five institutions where latex gloves were commonly used. Of the 
369 personal samples, 28 (7.6%) were negative controls i.e people not handling powdered 
latex products (administration). After sampling, the filters were sealed and stored in zipped 
plastic bags before analysis.  
 
Field blanks were included during sampling for quality control (QC) purposes.  Filters were 
handled in the same way as the samples by exposing them to the same environment but not 
withdrawing air as with the true samples.  The blanks and controls were also analysed in the 
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same batch as the samples.  Samples were randomly selected and sent to BGFA in Germany 
and FITkit Ltd in Finland for interlaboratory comparison. 
 
3.4.3 Rubber products 
A total of 19 latex rubber products (14 gloves and 5 dental dams) representing six brands were 
collected from the various dental schools. These included 13 powdered and 6 non-powdered 
latex products. Information for each rubber product was collected and recorded in a 
walkthrough checklist. These included sample type, powdered or non-powdered, brand  and 
specification of protein levels. The brand names of the rubber products could not be disclosed 
for ethical reasons, and were coded brand 1 to 6. The products were sealed and stored in 
labelled zipped plastic bags before analysis. Three rubber samples (2 gloves and 1 rubber 
dam) were sent to BGFA (Germany) and FITkit (Finland) for external quality control. 
 
3.5 SAMPLE ANALYSIS 
Among the healthcare workers, hev b 5 and hev b 6.02 have been shown to be the two most 
important latex allergens (Koh et al., 2005), thus these two allergens were selected for the 
analysis of airborne filter samples for this study. 
 
3.5.1 Extraction of filter samples 
Filter membranes were aseptically removed from the filter cassettes using forceps. The 
membranes were eluted in 6 ml limulus amoebocyte lysate (LAL) water with 0.1% Tween 20 
by stirring for 3 hours. The extracts (6ml) were freeze dried using a Crodos  
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-50°C freeze dryer (Labotec, Spain) and reconstituted in 1ml of 0.1% LAL-Tween. The 
supernatant was stored in micro centrifuge tubes at -70°C until analysis. 
 
3.5.2 Extraction of latex rubber products 
Gloves and dental dams from various institutions were cut into small pieces and weighed.  
One gram of rubber sample was extracted in 5ml phosphate buffered saline (PBS) with 0.1 % 
Tween 20 (1:5 w/v) at pH 7.4.  The samples were shaken at 160 rpm for 2 hours at 28°C±2 in 
a shaking incubator.  After shaking, the rubber solids were removed and the extracts were 
transferred into 1.5 ml centrifuge tubes and centrifuged (Hettich Mikro22R, Germany) at 
12000 rcf for 15 minutes at 25°C. The supernatant was filtered using 25mm, 0.45µm 
Acrodisc® filter membranes (Life Sciences, Pall Corporation, USA) and stored at -20°C prior 
to analysis. 
 
 3.5.3 Estimation of total extractable proteins in latex products 
Filter and rubber extracts were analysed for total protein content using the detergent 
compatible (DC) protein assay kit (BIO-RAD, Hercules, CA). The protein assay kit is a 
colometric assay for protein concentration following detergent solubilisation and is available 
commercially as a ready-to-use total protein assay kit. The assay is based on the reaction of 
protein with an alkaline copper tartrate solution (Reagent A) and folin reagent (Reagent B). 
The copper treated protein reduces folin reagent thereby producing a blue colour with 
maximum absorbance at 750 nm and minimum absorbance 405nm. The reaction is similar to 
the well documented Lowry assay but with colour development in a shorter period of time (15 
min). The total protein content in this study refers to the total extractable protein. 
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The assay was performed according to the manufacturer’s instructions. In summary, 20 µl of 
reagent S (surfactant solution) was added to 1ml of reagent A needed for the run depending on 
the volume needed for samples (reagent A can be used directly if samples do not contain 
detergent). A two-fold serial dilution ranging from 0.2 to 1.2mg/ml of protein standard was 
prepared for the standard curve.  Standards were prepared using bovine serum albumin (BSA) 
of concentration 1.44mg/ml (BIORAD, Hercules, CA) and PBS containing 0.1% Tween 20 as 
the diluent.  Five µl of standards and extracts were dispensed into a sterile microtiter plate.  
Working reagent A (25µl) was added into each well followed by reagent B (200µl).  The plate 
was gently agitated for approximately 5 seconds to mix the reagents, avoiding bubble 
formation.  After 15 minutes incubation, the optical density (OD) was read using a microplate 
reader (BIOTEK instruments, USA) at a wavelength of 750nm. A linear regression using KC4 
ELx808 software (BIOTEK instruments, USA) was used to determine the concentrations.  The 
results were expressed as µg/g for rubber extracts. The detection limit (DL) of the method was 
0.15mg/ml and the reporting limit (limit adjusted to the weight of rubber sample) was 
700µg/g. Results were acceptable if the correlation coefficient (R2) ≥ 0.98 and coefficient of 
variation (CV) was ≤ 10%. 
 
3.5.4 Quantification of latex aeroallergens  
The latex allergen content of filter and rubber extracts was determined using the FITkit TM 
(FIT Biotech, Tampere, Finland). FITkit is an immunological test based on the capture-
enzyme immunoassay (EIA) principle for direct determination of clinically relevant latex 
allergens (hev b 1, hev b 3, hev b 5 and hev b 6.02) in latex products. These kits use specific 
monoclonal antibodies developed against these four individual allergens with each allergen 
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providing results separately. For the purpose of this study, the two major allergens that have 
been reported in healthcare settings i.e. hev b 5 and hev b 6.02 were selected for the analysis 
of filter extracts.  The rubber extracts were tested for all four allergens to estimate the total 
allergen content.  The total allergen in this study refers to the sum of four clinically relevant 
allergens (hev b 1, hev b 3, hev b 5 and hev b 6.02).   
 
The microwell strips provided with the kit are coated with a monoclonal antibody that binds 
specific allergens from the sample extracts. The assay was performed according to the 
manufacture’s instructions. All reagents were brought to room temperature prior to testing.  
The test control was reconstituted with 500µl distilled water and was allowed to stand for 30 
minutes.  The wash concentrate (50ml) was diluted with 450ml of distilled water to make up 
500ml washing solution. 100µl of the assay buffer was added to the plate, followed by 25µl of 
standards, control and product extracts, respectively. All tests were performed in duplicate. 
The microwell plates were incubated for 1 hour at RT on a Stuart microtitre plate shaker 
(Labex, USA) at 200 rpm.  The microwell plates were washed four times using an automated 
PW 40 microplate washer (BIO-RAD, France).  After washing, 100µl of enzyme conjugate 
was added per well and incubated for 30 minutes at RT on a plate shaker.  The plates were 
washed again and 100µl substrate was added to start the reaction and the plates incubated for 
15 minutes.  The reaction was terminated by adding 100µl of the stopping solution.  The plates 
were shaken for 2 minutes and read on a microplate reader (BIOTEK instruments, USA) at 
405nm.  The allergen concentrations of extracts were calculated by log-log regression and 
spline curve fitting using software that fits the calibrator curve (KC4-ELX 808; BIOTEK 
instruments, USA).  The results were expressed as µg/l and the final results as mass protein 
per cubic meter of air (ng/m3). For QC purposes, each FITkit contains a test control which 
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should record results within a specified range provided in the certificate of analysis enclosed 
in the kit. 
 
3.6 STATISTICAL ANALYSIS 
Descriptive statistics were used and the airborne concentrations are reported by institution. 
Data analysis was first recorded and cleaned in MS Excel 2003 and imported to STATA 9 
computer software (StataCorp, 1984-2007, Texas, USA).   As the data of the allergens showed 
a skewed distribution, non parametric tests were applied and parametric tests (log 
transformed) was used were necessary.  ANOVA was used to test for significant difference 
between the means of the log-transformed values.  Two group comparisons were done using 
Wilcoxon rank-sum (Mann-Whitney) while multiple group comparison were done using 
Kruskal Wallis test. Data below the detection limit were censored using the Maximum 
Likelihood estimation (MLE) method (Hornung and Reed, 1990; Finkelstein and Verma, 
2001).  These methods involve the substitution of L/2 and L/√2 for each non-detectable value 
where L is the limit of detection. The latter was chosen for this analysis because it is reported 
to be more accurate for the estimation of mean and standard deviation when the data are not 
highly skewed. Spearman’s rank correlation coefficient was used to assess the relationship 
between total protein levels and total allergen levels.  A P-value of less than 0.05 was 
considered statistically significant. 
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Ethical clearance (M050512) was obtained from the University of Witwatersrand Ethics 
Committee.  Permission was also granted by various dental schools to conduct the study and 
consent was obtained from each participant (see attached appendices).  
 
Some institutions required that ethical clearance be obtained from their respective institutions 
(See appendices D-F). Permission was also granted from the Gauteng Department of Health 
(Provincial) to conduct the study. 
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CHAPTER 4 
 
4.0 RESULTS  
 
 
Inspection of dental clinics revealed that latex gloves (powdered and non powdered) and 
rubber dams were the most common latex products used in dentistry. The work practices (e.g. 
storage and disposal of latex products; and ventilation system) differed by institution. Of the 
four institutions (A, B, D, E) that have the ventilation systems, 3 (A, B, D,) were defective 
during the sampling period. Institution C did not have the ventilation system in place. The 
handling of latex products was good for some institutions and poor for the others. 
 
4.1 Personal samples 
 
The study population consisted of 454 participants who originally consented to participate in 
the study. However due to some participants withdrawing from the study and financial 
constraints, a total of 369 personal aerosol samples from all five institutions were analysed for 
the two latex allergens (hev b 5 and hev b 6.02) which have been reported in HCWs. The 
proportion of participants from each institution is shown in Figure 4.1.  
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 Percentage of participants per institution 
Institution A 
21%
Institution B 
26% 
Institution C
13%
Institution D 
17% 
Institution E
23% 
 
 
 
 
 
 
 
 
 
           Figure 4.1 A chart showing percentages of participants for various institutions. 
 
Of 369 personal samples, 28 (7.6%) were negative controls i.e administration staff not 
handling powdered latex products. Table 4.1 shows the proportion of staff from various 
departments found in various dental institutions. The participants included dental staff 
(clinical, laboratory, administration and auxiliary) and dental students (excluding first year 
students as they do not perform practical work). All staff and students working in the clinics 
were categorised as clinical. Laboratory staff included all technicians and technologists. 
Administrative staff included switchboard operators, secretaries and receptionists whereas 
auxiliary staff comprised of security, cleaners, porters, messengers and laundry personnel. Job 
types were categorised into 7 groups which included administration, laboratory technicians, 
dental assistants, students (DTOH and BDS), dentists and general assistants (auxiliary).   
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Table 4.1 Number of participants classified by department for different institutions 
Institution Departments: n (%) 
 Clinical Laboratory Administration Auxiliary Other*   Total 
A 61 (78.2) 6 (7.69) 3 (3.85) 8 (10.26) 0 (0.0)         78 
B 66 (70.2) 2 (2.1) 6 (6.4) 16 (17) 4 (4.3)          94 
C 37 (75.51) 2 (4.08) 1 (2.04) 8 (16.33) 1 (2.04)       49 
D 47 (74.6) 3 (4.8) 5 (7.9) 8 (12.7) 0 (0.0)          63 
E 63 (74.1) 2 (2.4) 13 (15.3) 7 (8.2) 0 (0.0)          85 
Total 274 (74.3) 15 (4.1) 28 (7.6) 47 (12.7) 5 (1.4)              369 
*not classified by department 
 
4.1.1 Detection limits (DL) of the enzyme immunoassay 
 
Approximately 50% of air samples demonstrated the presence of hev b 5, while hev b 6.02 
accounted for 14.6 % samples.  The remaining proportion was below the detection limit for 
both allergens.  In addition, for some specimens, the lowest calibrator (5µg/l) was diluted 
further to 2.5µg/l for quantifying hev b 5 and hev b 6.02 latex allergens. This step was 
necessary to broaden the detection range because several samples could not be detected. The 
descriptive analysis for hev b 5 and hev b 6.02 allergen concentrations in personal air samples 
is presented in Table 4.2. All observations below DL were censored as described in chapter 3. 
 
Table 4.2 Summary description for hev b 5 and hev 6.02 detection levels 
Allergen (µg/l) Detection limit (DL) n (%) 
Hev b5        (n=367) Below DL <2.5* 109 (29.7) 
 Below DL <5 75   (20.4) 
 Detected 183 (49.9) 
Hev b6.02  (n=369) Below DL <2.5 319  (86.5) 
 Detected 50    (13.5) 
* 5 µg/l calibrator diluted further to 2.5 µg/l to broaden the detection range 
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4.1.2 Summary description for hev b 5 and hev b 6.02 for personal air samples 
Overall, the median level for hev b 5 was 9.36ng/m3 with an interquartile range (IQR) of 
7.71ng/m3. The concentrations for hev b 5 ranged from 1.84 to 46.1ng/m3 for all institutions.  
Since hev b 6.02 had a high proportion of measurements below the DL, the data was analysed 
differently as a categorical variable. 
 
4.1.3 Hev b 5 and hev b 6.02 classified by institution 
Variations between institutions for hev b 5 allergen levels were assessed (Figure 4.2). Median 
(ng/m3) levels are indicated in the graph.   
 
       
      Figure 4.2 Graphical illustrations of hev b 5 concentrations by institution. Median values      
      in parentheses. 
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Figure 4.2 shows differences in the concentrations of hev b 5 between institutions. Institution 
B showed the highest median level (13.5ng/m3) and institution C the lowest median level 
(5.7ng/m3).  Kruskal Wallis test for the equality of population medians showed that the 
exposure levels differed significantly by institutions in terms of hev b 5 latex allergen 
(p≤0.001). To further test for significant difference between respective institutions, an 
ANOVA analysis (including Bonferroni comparison) was done on the log-transformed values 
of hev b 5 (Table 4.3). 
 
Table 4.3 Comparison of means of log-transformed values for hev b 5 by institution 
Institution   Arithmetic    Comparison difference (p-value) 
              mean      A   B  C  D 
A  2.30     -   -  -  - 
B  2.49     0.19 (0.095)  -  -  -  
C  1.78     0.51 (0.000)      0.71 (0.000) -  -  
D  2.15     0.14 (1.000)      0.34 (0.000)     0.38 (0.000)  - 
E  2.06     0.23 (0.03)      0.43 (0.000)     0.28 (0.022)   0.09 (1.000) 
 
 
The results of the log-transformed values demonstrated that personal exposure levels for 
institution B were significantly higher than all the other institutions except institution A 
(p<0.001).  Institution C was again significantly lower than all institutions which confirm the 
results obtained in Figure 4.2.  There was also a significant difference between institution A 
and E (p<0.05) as shown in Table 4.3. 
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Participants with detectable exposure levels (13.6 %) for hev b 6.02 were categorised as 
exposed and those below detectable levels (86.4 %) as unexposed as indicated in Table 4.4 
(Braimoh Bello, personal communication, 2007). The proportion of the exposed category to 
hev b 6.02 differed significantly by institution (p<0.001).  
 
Table 4.4 Proportion of exposed and unexposed category for hev b 6.02 by institution 
 
Hev b 6.02 allergen category (µg/l) 
Institution                     Exposed n (%)                  Unexposed n (%)                 Total n (%) 
A 32 (41.03)   46 (58.97) 78 (100.00) 
B 0 (0.00)     94 (100.00) 94 (100.00) 
C 1 (2.04)           48 (97.96) 49 (100.00) 
D 7 (11.11)           56 (88.89) 63 (100.00) 
E 10 (11.76)           75 (88.24) 85 (100.00) 
Total 50 (13.55)           319 (86.45) 369 (100.00) 
 
Table 4.4 shows that Institution A has a higher proportion of hev b 6.02 personal exposure and 
forms part of the 13.6% of the detectable levels for the allergen suggesting that more 
participants were exposed to hev b 6.02 than they were for hev b 5.  Theses allergens are two 
individual allergens analysed using two separate kits, therefore one allergen can be detected 
while the other cannot from the same sample. 
 
4.1.4 Concentrations of hev b 5 and hev b 6.02 by departments 
The differences in exposure levels of hev b 5 and hev b 6.02 between four departments 
(clinical, laboratory, administration and auxiliary) were assessed. The medians levels (ng/m3) 
for hev b 5 are indicated in Figure 4.3. 
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      Figure 4.3 Personal exposures levels of hev b 5 by departments.  
 
The results illustrate a difference in the levels for hev b 5 (Figure 4.3) by departments. The 
clinical and laboratory departments showed higher concentrations of hev b 5 than the 
administration and auxiliary departments.  Kruskal Wallis test showed that the exposure levels 
differed significantly by departments in terms of hev b 5 latex allergen (p=0.0113). An 
ANOVA analysis (including bonferroni comparison) on the log-transformed values of hev b 5 
showed further significant differences between the clinical and auxiliary departments 
(p=0.029) . Table 4.5 illustrate the proportions of hev b 6.02 by department which is 
significantly different (p=0.027). 
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Table 4.5 Proportion of exposed and unexposed category for hev b 6.02 by departments 
Hev b 6.02 allergen category (µg/l) 
Institution                            Exposed n (%)                Unexposed n (%)          Total n (%) 
Clinical 46 (16.79) 228 (83.21) 274 (100) 
Laboratory 1 (6.67) 14 (93.33) 15 (100) 
Administration 2 (7.14) 26 (92.86) 28 (100) 
Auxiliary 1 (2.13 46 (97.87) 47 (100) 
Total 50 (13.74) 314 (86.26) 364 (100) 
 
 
4.1.5 Concentrations  of  hev b 5 classified by the type of tasks 
 
The differences in exposure levels for hev b 5 between tasks are presented in Table 4.6. 
Although the median values for various jobs were similar, the maximum values differed 
markedly. It is evident that the clinical staff and students are exposed to higher levels of  
hev b 5. 
 
Table 4.6 Hev b 5 concentrations for personal samples by job category 
Job tasks Median Lower and upper 
quartiles 
Min and Max 
range 
Laboratory (n=14) 10.6 6.2, 14.2 4.4, 19.3 
Administration(n=27) 9 4.8, 9.8 2.8, 17.1 
DTOH* (n=41) 9.4 5.9, 12.5 3.9, 35.5 
BDS** (n=78) 11.5 8.4, 15.3 1.84, 46.1 
Assistants (n=118) 9 5.2, 12.7 3.6, 20.1 
Dental staff (n=34) 9.6 6, 14 3.6, 27.2 
Auxiliary (n=47) 7.4 4.7, 11 2.8, 21.4 
*Dental therapy and oral hygiene students, **Bachelor of Dental Science 
 
Kruskal Wallis test showed significant difference between the job tasks in terms of hev b 5 
latex allergen (p=0.0035). Further test (Bonferroni) on the log-transformed values of hev b 5  
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demonstrated that the BDS students differed significantly with the administration (p=0.046); 
assistants (p=0.032); and auxiliary (p=0.001).  
 
The proportions of hev b 6.02 by the type of job was also significantly different (p<0.001) as 
indicated in Table 4.7. 
 
Table 4.7 The Proportion of the exposed and unexposed group for hev b 6.02 by  job category 
Job tasks Exposed 
n (%) 
Unexposed 
n (%) 
Total 
n (% 
Laboratory 1 (7.1) 13 (92.9) 14 (100) 
Administration 2 (7.1) 26(92.9) 28 (100) 
DTOH* 4 (9.8) 37 (90.2) 41 (100) 
BDS** 26 (32.9) 53 (67.1) 79 (100) 
Assistants 9 (7.6) 110 (92.4) 119 (100) 
Dental staff 7 (19.4) 29 (80.6) 36 (100) 
Auxiliary 1 (2.1) 46 (97.9) 47 (100) 
Total 50 (13.7) 314 (86.3) 364 (100) 
*Dental therapy and oral hygiene students, **Bachelor of Dental Science 
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4.2 Area samples 
 
A total of 95 area sample extracts were analysed for the presence of two latex allergens.  Table 
4.8 summarizes the detection levels for both allergens using the FITkit assay. 
 
Table 4.8 Summary description for hev b5 and hev 6.02 detection levels for area samples 
Allergen (µg/l) Detection limit (DL) n (%) 
Hev b 5       (n=95) Detectable 45 (47.4) 
 Below DL <2.5* 30 (31.6) 
 Below DL <5 20 (21) 
Hev b 6.02  (n=93) Detectable 4   (4.3) 
 Below DL <2.5* 89 (95.7) 
* 5 µg/l calibrator diluted further to 2.5 µg/l to broaden the detection range 
 
 
4.2.1 Summary description for hev b 5 and hev b 6.02 for area samples  
The median detection level of area samples was 2.96ng/m3 with an interquartile range (IQR) of 
2.68ng/m3. The concentrations for area samples for all institutions ranged from 1.33 to 
14.97ng/m3.  The presence of hev b 6.02 could not be detected in a high proportion of area 
samples assessed (Table 4.8). The presence of this allergen was therefore not analysed further. 
 
 
4.2.2 Hev b 5 concentrations classified by institutions for area samples 
 
Figure 4.4 illustrates the difference in concentrations of hev b 5 between institutions. The 
concentrations of hev b 5 allergen differed significantly by institution (p=0.002).  The 
concentration was highest for institution B with a median value of 5.6 ng/m3 and lowest for 
institution D, with a median value of 1.6ng/m3. 
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        Figure 4.4 Hev b 5 concentrations for area samples of various institutions. Median values  
        in parentheses. 
 
The log-transformed values of hev b 5 were used to compare institutions. The results showed 
that the exposure levels for institution B were significantly higher than all other institutions 
(p<0.001). However, there was no significant difference between the remaining institutions. 
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4.3 Latex rubber products 
 
4.3.1 Quantification of hevein allergens and total protein 
 
Of the 19 samples of rubber products (14 gloves; and 5 dental dams) representing six brands, 
13 were powdered and 6 were non-powdered. Hev b 1 was detected in 80% (4/5) of dental 
dams but not in gloves, however hev b 3 was found in 89% (17/19) of gloves and all dental 
dams, hev b 5 in 93% (13/14) of gloves and all dental dams. All rubber samples of gloves and 
dental dams analysed demonstrated the presence of hev b 6.02. The concentration of the 
allergenic proteins in relation to their total protein content is summarised in Table 4.9.  Hev b 
1 concentrations were the lowest of the four allergens, ranging from <0.05 (noted as 0) to 
7.9µg/g whereas the concentration of hev b 6.02 detected was markedly higher ranging from 
<0.025 to 61.5µg/g. The concentration of hev b 3 found ranged from <0.05 to 30.12µg/g and 
hev b 5 from <0.025µg/g to 9.2 µg/g.  The total protein content could only be measured only 
in 12 samples and was below the detection limit (700µg/g) for 7/19 (37%) extracts (Table 4.9). 
Regarding total allergenic protein content of the extracts (also referred to as total 
allergenicity), 14/20 fell in the high category, 4 tested as moderate and 1 was low. 
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Table 4.9 Comparison of four latex allergens and total extractable protein concentrations in 19 latex rubber extracts. 
Allergen concentrations in extracts 
(µg/g of glove) 
Sample 
ID 
Sample 
type 
Powdered/Non
-powdered 
hev b1 hev b3 hev b5 hev b6.02
Total 
allergen 
(µg/g) 
Total 
protein 
(µg/g) 
Allergeni-
city 
1 glove powdered 0 0.1 9.2 38.39 47.69 3130 high 
2 glove powdered 0 0 0.27 46.09 46.36 2740 high 
3 glove powdered 0 2.69 6.87 15.46 25.02 3180 high 
4 glove powdered 0 0.05 3.62 20.12 23.79 3380 high 
5 glove powdered 0 0.22 4.1 11.64 15.96 2080 high 
6 glove powdered 0 1.25 4.74 0.3 6.29 <700 high 
7# glove powdered 0 0.45 0.3 2.75 3.5 <700 moderate 
8 glove powdered 0 0 2.84 0.56 2.99 770 moderate 
9 glove non-powdered 0 24.71 0.24 11.09 36.04 2150 high 
10 glove non-powdered 0 17.43 1.96 0.09 19.48 <700 high 
11 glove non-powdered 0 2.13 4.23 0.36 6.72 <700 high 
12 glove non-powdered 0 3.67 2.32 0.23 3.9 <700 moderate 
13 glove non-powdered 0 3.59 2.45 0.15 2.81 <700 moderate 
14 glove non-powdered 0 0.58 0 0.09 0.67 <700 low 
15 dam powdered 7.9 18.31 5.26 61.5 92.97 2790 high 
16 dam powdered 0.31 30.12 4.44 55.53 90.4 3130 high 
17 dam powdered 0.12 25.69 3.26 51.84 80.91 3230 high 
18 dam powdered 0 1.53 4.52 54.3 60.35 2610 high 
19 dam powdered 0.72 0.1 2.15 37.57 40.54 3360 high 
Detection limits (DL): hev b 1=0.05 µg/g, hev b 3=0.05 µg/g, hev b 5=0.025 µg/g, hev b 6.02=0.025 µg/g, Total protein=700 µg/g 
Values below DL for allergens are recorded as zero. 
# reduced protein 
4.3.2 Correlation between total allergen and total protein of latex rubber products 
As shown in Figure 4.5, statistical analysis revealed that the total allergen in 19 latex 
rubber products correlated well with the total protein content (Spearman’s r=0.74,    
p<0.001, n=19). The graph includes data for all latex products analysed. 
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 r = 0.74  
P<0.001  
 
 
 
 
 
 
 
 
 
Figure 4.5 Correlation between the total allergen and total protein expressed as µg/g of     
latex extracts in 19 samples. 
 
 
4.3.3 Comparison between different latex products  
A two-sample (Mann-Whitney) test showed a significant difference (p=0.002) between the 
latex concentrations of gloves and dental dams. Hev b 1 and hev b 3 are more common 
allergens in the dental dams as compared to the gloves (Figure 4.6). Similarly there was a 
significant difference (p=0.035) between powdered and non-powdered samples (Figure 
4.7). Powdered latex products showed higher concentrations of total allergen content 
compared to the non-powdered products. A comparison of the latex concentrations of the 
various branded latex products also showed a significant difference (p=0.022) using the 
Kruskal Wallis test (Figure 4.8).  
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    Figure 4.6 Comparison between the four hevein allergens (µg/g) in gloves and     
          dental dams. 
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    Figure 4.7 Comparison between the total allergen (µg/g) in powdered and     
    non-powdered samples. Medians (powdered=40.54µg/g, non-powdered = 
    5.31µg/g). 
 
 
4.3.4 Comparison between total allergen content of different brands of latex rubber 
products 
In Figure 4.8, brand 3 which is dental dams (median: 80.91µg/g) showed higher 
concentrations followed by brand 1 (median: 24.40µg/g) and brand 2 (median: 11.34µg/g). 
Brand 4 and 6 were not statistically represented (one sample per brand). They are however 
included herein for the purpose of demonstrating the difference in allergen concentrations 
of the different brands. Brand 5 was found to be present in much higher concentrations 
(median: 36.04µg/g) than most glove brands whereas brand 6 showed the lowest 
concentration (median: 6.29µg/g). 
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    Figure 4.8 Comparison between the total allergen (µg/g) in different brands (1-6) of  
    latex products. 
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CHAPTER 5 
 
 
5.0 DISCUSSION  
 
This study used a combination of air sampling, immunological and statistical techniques to 
determine the concentrations of clinically relevant allergens in 5 dental schools within 
South Africa. The present study has shown that airborne allergen concentrations vary 
considerably among the five participating dental schools. The concentration of latex 
allergens for personal samples in this study were 2.8 to 46.1ng/m3 for hev b 5 and 1.1 to 
46.2 ng/m3 for hev b 6.02. These levels were lower than those reported by Swanson et al 
(1994), which varied from 8 to 978ng/m3. The differences may be attributed to the varying 
sampling methodology. In our study we used a similar sampling principle at a flow rate of 
2.5L/min, whilst Swanson et al used a flow rate of 5L/min for personal sampling which 
may have contributed to the measurement difference. Furthermore the detection technique 
we utilised was based on ELISA principle rather than inhibition assay. 
 
In this study, differences were also observed when comparing different personnel 
categories, referred to as departments in the previous chapter i.e clinical, laboratory, 
administration and auxiliary. Individuals based in the clinical department were exposed to 
the highest levels of hev b 5 (37.1ng/m3) compared to those in the other departments. It is 
possible that the high levels of exposure maybe due to various dental procedures done in 
this department. Each clinic session requires change of gloves, most of which were 
powdered; hence the risk of exposure increases with each change of gloves. In addition, 
procedures which require the use of dental dams which were also powdered increase the 
risk of exposure.  Analysis of exposure to hev b 5 also showed higher concentration of this 
allergen in the laboratory department compared to the auxiliary department (Figure 4.3).  
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In the current study, the administration department was used as a control group as the risk 
of exposure to latex allergens was thought to be minimal in this category. The auxiliary 
department on the other hand was exposed to latex allergens very rarely because the 
majority of personnel in this category did not wear gloves nor use the dental dams. It was 
therefore somewhat surprising to note that the median levels of exposure in the 
administration department (median: 8.9ng/m3) was slightly higher than the one observed in 
the auxiliary department (median: 7.4ng/m3). However the standard deviation between the 
two categories overlap and these median differences are minor. Nevertheless the allergen 
level in both departments was markedly lower than observed in the clinical and laboratory 
departments. During our surveys, we observed that both the dental staff and students wore 
their labcoats in common areas (canteens, rest rooms and offices) which may have lead to 
allergens being transferred to other areas. The trace levels of latex aeroallergens may also 
be transported to the offices on equipment and footwear of workers moving between the 
work area and offices (Sri-Akajunt et al., 2000). Thus workers not directly involved with 
latex products may also be exposed to latex aeroallergens. Moreover, the administration 
departments of most of the dental institutions are in close proximity to the clinics thus 
resulting in transfer of latex aerosols. This finding suggests that the frequent use of latex 
products in the dental clinics does contribute to airborne latex particles. 
 
Furthermore, our study has demonstrated that exposure to latex allergens differ by the type 
of work performed. The Bachelor of Dental Science (BDS) students have shown higher 
latex concentration than permanently employed personnel. The difference is significant for 
assistants, auxiliary and administration and not significant for dental staff although the 
median and maximum levels are higher for BDS students than the dental staff.  This 
difference could be attributed to the fact that students come into contact with patients 
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throughout the day in the clinics and are directly and more frequently exposed to latex 
allergens compared to other staff; and dentists who only supervise the dental processes and 
occasionally wear gloves.  
 
The occupational exposure limits for latex allergens causing sensitisation and symptom 
provocation are currently not documented in South Africa. An industrial hygiene study 
reported a high risk potential for triggering allergic reactions when latex levels exceeded 
50ng/m3, with moderate risk potential of 10-50 ng/m3 particularly to atopics and low risk 
of allergic reaction at levels less than 10ng/m3 depending on an individual’s immune 
system (Reiter, 2002; Hunt et al., 2002; Mc Fadden, 2002).  Adopting this recommended 
OEL, the ranges were classified as low (<10ng/m3), moderate (10-50ng/m3) and high risk 
(>50ng/m3). Our results are similar to those reported by Quirce et al (2004) who also 
showed a range of moderate to high latex aeroallergen concentrations in ambulances where 
personnel used powdered latex gloves. Several other studies have demonstrated that a latex 
level of 0.6ng/m3 or greater induced occupational respiratory responses (e.g. conjunctivitis, 
rhinitis and asthma) as well as the development of latex specific antibodies (Baur, 1998; 
Baur, 2002; Swanson and Ramalingam, 2002).  If we were to adopt this cut-off for our 
study, the risk of personal exposure to latex allergens will be increased 2 to 77 times higher 
(1.1 to 46.2ng/m3) than what our current cut-off allows. The study presented here therefore 
suggests that for individuals such as those in the dental care profession, the latter cut-off 
which would result in lower limits be applied, thus providing less exposure to latex 
allergens by these individuals, particularly atopics. 
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A second aspect of the study examined 95 air samples from work areas of five dental 
schools for their content of latex allergens. The results of our study show that latex 
aeroallergens vary considerably among the dental schools (Figure 4.4). The overall latex 
concentration levels for area samples taken from all participating institutions ranged 
between below the detection level to 14.97ng/m3 for hev b 5 allergen. These exposure 
levels were considerably lower than those reported by Allmers et al., 1998 (0.86 to 49.93 
ng/m3) Swanson et al., 2001 (13 to 121ng/m3), Baur et al., 2002 (0.4 to 240 ng/m3).  
 
In general, although the exact number of individuals exposed could not be identified (not 
all students and personnel participated in the study), the dental clinics of institution A, B 
and E were identified as having high numbers of staff and students. Institution C and D on 
the other had reflected lower numbers of staff and students. It is therefore interesting to 
note that the latex levels of these three institutions were higher with the most significantly 
raised levels found in Institution B (Figure 4.4).  Consequently, the constant and obviously 
more frequent donning and removal of gloves by a higher number of cohorts could result 
in the possibility of greater exposure as evidenced in figure 4.4; although the most 
significant was only observed in institution B. This corroborated with Swanson et al., 
1994. 
 
Institution B, the largest of the institutions showed higher exposure levels than institution 
D which was the lowest. Institution B clinics were also busier during the sampling periods, 
thus more procedures were performed resulting in more glove changes which may have led 
to high levels of latex allergens. In addition the ventilation system of institution B was 
defective during the sampling period which could also explain the high allergen 
concentrations.  Institution E was the only institution with functioning ventilation but did 
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not show the lowest exposure to aeroallergens. This finding suggest that the ventilation 
system for Institution E was either not well maintained, however it was difficult to reach a 
conclusion as the service records were not available during the walkthrough nor were they 
available at a later stage.  It is also possible that the ventilation system was not effective in 
diluting the particles as the systems were centralized and the dental procedures were 
performed in cubicles in Institution E.  In addition except for the ventilation system, there 
are other possible determinants of exposure such as work practices (surface cleaning, 
disposal of gloves) and the frequency of glove usage. The current study aimed to determine 
if airborne latex particles could be detected in dental schools, and to record the presence 
and absence of ventilation equipment and the working condition thereof at the time of 
sampling. In that case the administrative department was included as the control instead of 
an institution with a functioning ventilation system, as the administration department was 
expected to have low latex levels since the participants did not use latex products. 
 
In this study an association between aeroallergen levels and the number of gloves used was 
not investigated as reported by (Baur et al., 2002) and (Swanson et al., 2001). However, 
our findings suggest that the use of powdered latex products resulted in the presence of 
detectable allergen levels as most dental schools used powdered products. The recording of 
gloves would have been ideal and was considered at the initial stage of the study but was 
not easy to execute due to the minimum number of the study team members who were 
responsible for setting up the equipment, monitoring the equipment during work 
operations, recording the sampling data before and after sampling, performing a 
walkthrough. In addition, the clinic sessions took place in different clinics at different 
times.with 15-30 students performing tasks per clinic, depending on the number of patients 
per session. The other reason is that one student or staff changed gloves per patient if 
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deemed necessary which would complicate the process more. Another option would have 
been to wait until the session is finished and count the gloves; however this was a risk of 
exposure to biological hazards as the gloves will be mixed with other potential hazardous 
substances. In addition, with the infection control awareness programmes at the 
institutions, most clinics were cleaned after each session and sometimes biological waste 
was discarded. The whole academic setup in dental clinics was not easy to manage as a 
result of student groupings, the timetables (sessions versus lectures) and locating 
participants who gave consent for sampling, thus making it difficult to count the gloves 
used per participant. 
 
In general, area samples showed lower concentration of hev b 5 allergen than personal 
samples in our study. It has been reported that area (static) sampling usually collects 
significantly less allergen than personal sampling (Renstrom, 2002) due to a dilution effect 
of the environment. This is in contrast to a possible higher recording of allergens in close 
proximity to individuals handling latex in personal sampling. This may then explain the 
lower levels found for area sampling in our study. 
 
It is also possible that the capture ELISA kit is not sensitive enough for air samples as the 
allergen are at too low concentration for detection by this assay. It has also been postulated 
that latex allergens could adhere to particles >10µm that settles rapidly, which could also 
influence the detection levels (Brown et al., 2004). The latter however was not proven in 
our study.  The other possible explanation could be that the extraction method used in our 
study did perhaps not wash out all the latex allergens, and therefore the levels found do not 
compare well with other studies. 
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To our knowledge, our study is the first nationally and one of a few globally to adapt the 
FITkit assay for quantification of airborne latex allergens. Thus the sensitivity of this kit 
for air samples is not readily available. However, the Health and Safety Laboratory (HSL) 
in the UK quantified latex allergens from air samples using FITkit in a braiding factory. 
This study detected hev b 6.02 in 9/14 personal air samples ranging from below DL to 
3.1µg/m3 (equivalent to 3100ng/m3), which is 67 fold of the results we found.   Hev b 1, 
hev b 3 and hev b 5 were undetectable in this study (Elms et al., 2005). This difference 
may be explained by the type of setting from where the samples were collected, the source 
of latex used and the levels of the allergen present in the latex source that could be 
aerosolised. 
 
The estimation of latex aeroallergens in work areas is a necessary step in the evaluation of 
latex sensitivity of workers. Information on the levels of airborne latex allergen is 
necessary to confirm the existence and extent of distribution of the concentrations of 
allergens. This could develop into determining interventions which would alleviate the 
indoor aeroallergen exposure, thus reducing sensitisation and improving symptoms in 
workers who are allergic to latex (Swanson et al., 2001).  Air sampling and analysis of the 
allergens provide an objective means of evaluation for this purpose. Changing to non-
powdered or low allergen latex products appears to be the most effective method to control 
exposure to airborne allergens (Baur, 2002). 
 
Several investigations have demonstrated that powdered latex gloves are the major 
contributor to atmospheric latex aeroallergens found in many areas of medical centres, 
especially in dental schools (Allmers et al., 1998; Swanson et al., 2001; Hunt et al., 2002; 
Schmid et al., 2002). Our findings confirm these previous reports by demonstrating that 
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powdered gloves are a source of latex in the workplace. In addition, our study has also 
shown that the dental dams contain much more allergens as compared to the gloves. The 
dams contain hev b 1 allergen which could not be detected in the gloves; and also higher 
levels of hev b 3 than hev b 5 as compared to the gloves. The dental dams used in the 
dental settings are powdered and therefore provide a source of aerosolised latex allergen.  
However, one limitation of our study is that hev b 1 and hev b 3 allergens were not 
included in the analysis of air samples due to budget constraints. 
   
There is currently no standardised method for determining the allergenic content of latex 
materials mainly because the allergens have not been accurately identified (Vandenplas, 
1995). Total protein measurements currently serve as a useful indicator of the exposure to 
latex allergenic proteins (Beezhold, 1996; Audo, 2004).   For evaluation of allergic 
respiratory responses to occupational latex exposure, the information regarding allergen 
content in medical gloves in use is useful, in addition to quantification of latex 
aeroallergens (Kujala et al., 2002). Previous research has documented that the total protein 
levels does not necessarily correlate with allergen content (Lee et al., 2006). However our 
results have shown a significant correlation (Spearman’s, r = 0.74, p<0.001) between the 
total protein content and total allergen (Figure 4.5). Nevertheless, there are limitations to 
the protein assay; and the fact that this method measures all extractable proteins and cannot 
differentiate between allergenic and non allergenic proteins (Audo et al., 2004) is 
recognised in the present study.  
 
Previous research has shown that some latex gloves have high total protein content but low 
NRL allergen concentration and vice versa (Palosuo et al., 2002). Other allergens such as 
cow’s milk casein, which is used as stabilisers during the glove manufacturing process, 
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have been identified in glove extracts (Ylitalo et al., 1999). This casein content was almost 
half of the total protein (400/1000µg/g) suggesting that the total protein content is not a 
good measurement for latex allergen content of rubber products (Ylitalo et al., 1999). Our 
results illustrates that all the samples that were below the DL for total protein (<700µg/g) 
had total allergen content albeit low, compared to those with high protein content. The 
finding confirms that measuring protein alone is not useful for latex products with 
<700µg/g protein per gram of sample.  However the results of the present study show a 
good correlation of total protein content and total allergen content (Fig 4.5). The present 
study therefore suggests a place for the use of correlating total protein and allergen content 
in evaluating latex allergen exposure. Alternatively, due to socio-economic reasons the 
developing countries using latex products could use the protein assay as a screening tool to 
estimate allergens in the products. 
 
The Food and Drug administration (FDA) have introduced the modified Lowry method 
(ASTM D5712) to measure the total soluble protein content of gloves and has 
recommended the cut-off limit of 50µg protein per gram of glove (Charous et al., 2002; 
Audo et al., 2004). This cut-off value was a consequence of discussions between various 
regulatory groups (Audo et al., 2004).  In the present study, a modification of the Lowry 
method was used with reduced processing steps thereby saving valuable time and 
preventing the loss of detectable proteins. The results show that, 7/19 (37%) samples 
demonstrated proteins <700 µg/g and they fall above 50µg/g range.  Future protein studies 
and technology could look at the current detection limit of 50µg/g. This could make a 
significant difference in the allergenicity of the product.   
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In the present study, hev b 1 was not detectable in most of the latex rubber extracts. 
Similarly, (Palosuo et al., 2007) detected hev b 1 only in a few glove samples in their 
study. Our results contrast those by (Lee et al., 2006) who demonstrated that hev b 1 was 
predominant in latex gloves used by medical personnel in Taiwan. The two allergens (hev 
b 5 and hev b 6.02) that have been previously reported to be the most abundant allergens in 
gloves (Palosuo et al., 2002; Sutherland, 2002) were present in all the samples in the 
current study.   
 
Palosuo et al., 2002 reported positive skin test reaction to gloves in latex allergic patients 
when the sum of four allergens exceeded 1µg protein/g of glove (Palosuo et al., 2002). In 
the present study all the samples assessed were above this limit with the exception of one 
(sample 14) which contained 0.67µg/g and this was categorised as low allergenicity in the 
present study (Table 4.9). Total protein content for the latter was also below the limit of 
detection.  Latex products in the low allergenicity category contain such low levels of the 
natural rubber allergens that they are suitable not only for non allergenic individuals but 
also for most of the sensitised users (Wagner et al., 2005). 
 
Sample 7 which demonstrated reduced protein levels also had total protein below the DL. 
However the total allergen content was 3.5µg/g for this sample which is above the 1µg/g 
limit, indicative of moderate allergenicity (Palosuo, 2002). This observation confirms 
previous reports that some products have low extractable proteins but high allergenic 
proteins (Palosuo et al., 2002). 
 
It is common knowledge that the latex allergen content seems to be higher in powdered 
gloves than in non-powdered gloves (Kujala et al., 2002). The present study is in 
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agreement with this by reaffirming that powdered latex samples have high allergen levels 
than non-powdered latex samples (Figure 4.7). Although non-powdered gloves have lower 
allergens, they are nevertheless high enough to cause sensitisation with 50% of sample 
tested reflecting high allergenicity and 33% demonstrating moderate allergenicity (Table 
4.9).   
 
Most latex products currently used in dental schools in South Africa are powdered and may 
contribute to latex aeroallergen load in the dental clinics and may consequently trigger 
allergic reactions, not only in workers but patients as well. The information gathered 
during the survey showed that all institutions used both powdered and non-powdered latex 
gloves simultaneously except institute A which only used powdered latex products at the 
time of sampling. All the rubber dams were powdered for all institutions. The rubber 
samples were randomly collected from the working stations were both powdered and non 
powdered products were stored. It is therefore difficult to state whether powdered or non-
powdered gloves were used more often in a specific clinic in order to justify the levels in 
the air. In addition work practices (e.g. how gloves are put on and removed) also has an 
impact on the aerosolised latex concentrations. The type of procedure performed may also 
play a role in airborne latex levels e.g dental rubber dams which showed high allergen 
content than latex gloves are only used for certain procedures. If the dental dams are not 
used, not much protein will be released into the air thus low latex levels will be detected at 
the time and vice versa. It can therefore be concluded that the type of latex product used 
and whether it is powdered or non powdered do somehow contribute to the aerosolised 
latex protein, taking into consideration all the other factors such as ventilation, work 
practices, number of patients seen , number of students or staff,  duration of clinic session, 
size of the clinic etc. 
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Results from a few studies done in dental schools demonstrated a significant reduction in 
latex allergy in dental students after switching from relatively high protein, powdered latex 
gloves to low protein, non -powdered NRL gloves (Liss and Tarlo, 2001; Wrangsjo et al., 
2001; Saary et al., 2002; Jones et al., 2004). Another study showed that the use of non-
powdered, low protein latex products resulted in reduced levels of airborne latex allergens 
and was effective in allowing a laboratory worker with latex induced OA to return to work 
(Liss and Tarlo, 2001). 
 
Generally researchers agree that there may be considerable differences between different 
brands of gloves, manufacturers and even between gloves of different batches from the 
same manufacturer (Kujala et al., 2002; Palosuo et al., 2002). The present study has shown 
the difference between brands of latex products used (Figure 4.8).  Brand 3 (dental dams) 
demonstrated the highest concentration of total allergen content and brand 4 the lowest. 
Interestingly, sample 14 which was below the limit of 1µg/g for the sum of four allergens 
is brand 4 which had the lowest concentration and is collected from institution C which 
had lower airborne latex levels (pg 39 and 46). Sample 7 which declared reduced protein 
and also showed extractable proteins below the DL is also brand 4.  All of these indicate 
that brand 4 would contain the lowest levels of allergen and extractable protein and is 
therefore the brand of choice from this study. It has been suggested that powdered latex 
products are acceptable if the protein content is low, however assessment for development 
of allergic reactions should be maintained (Charous et al., 2002). These products are often 
provided to a minority of personnel diagnosed with latex allergy by a healthcare 
practitioner. 
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Our study demonstrated that measuring individual allergens using capture ELISA assay is 
a reliable method for evaluating the allergenicity of latex products which will assist in 
setting up occupational exposure limits (OELs) for safety purposes which could become a 
guideline to authorities, manufacturers, industries and consumers in South Africa.  Our 
study also shows that this method is more sensitive than the currently used total protein 
measurement. This is also supported by other studies (Palosuo et al, 2002; Ylitalo, 1999). 
Our study has also proven that NRL allergens in the latex materials used in dental schools 
of South Africa are present at levels high enough to cause NRL allergy.  
 
Adopting a powder-free, low protein policy will provide healthcare workers with a strategy 
for preventing occupational exposures to latex allergens. NIOSH and OSHA are supporting 
this recommendation (Lopes et al., 2004). Our findings serve as evidence for a possible 
requirement to adopt a glove selection and/or powder free policy for South Africa as it has 
been recommended in other countries such as UK, Canada and Scandinavia and Germany 
(Potter, 2001). It is suggested that a requirement be that manufacturers should produce 
latex products with low allergen levels and at least declare the allergen levels on the 
package inserts. The challenge is for healthcare administrators to purchase low allergen 
products thus decreasing the overall rates of sensitisation in workers using latex products.   
 
Research data has also indicated that changing to low allergen gloves alone will not be 
sufficient to create a latex safe environment because of other sources of latex, such as 
transfer of allergen from less restricted sites, either on clothing, footwear, ventilation ducts, 
or from equipment moved from one room to another (Sri-Akajunt et al., 2000; Hunt et al., 
2002; Heilman et al., 1996; Mitakakis et al., 2002). Therefore, workers should be educated 
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on the safety, care and clinical practices. Management should also be aware of the 
importance of maintenance of the ventilation systems. 
 
Previous studies suggested methods for measuring NRL allergen levels in air samples and 
latex rubber products. However, most methods are based on human IgE based reagents 
which cannot be standardised due to variable antibody reactivity of given pool sera and/or 
lack of standardised allergens (Palosuo et al., 2002; Koh et al., 2005). The IgE based 
assays includes RAST inhibition assay, CAP system and SDS-PAGE immunoblotting 
(Swanson et al., 1994; Swanson et al., 2001; Baur 2002). Using these techniques is also 
limiting because human serum containing IgE antibodies to hev b 1 and hev b 3 is scarce 
(Palosuo et al., 2002). Several clinically relevant allergens can now be measured by 
immunoassays using monoclonal antibodies and recombinant allergens. These methods are 
specific, sensitive and can be standardised (Palosuo et al., 2002). It should be noted that, 
except for hev b 6.02, little is known about the molecular forms of proteins that can resist 
the glove manufacturing process and retain their allergenicity (Palosuo et al., 2002; 
Tomazic-Jezic and Lucas, 2002).   
 
The present study acknowledges several limitations which include the inadequate sample 
size of the latex rubber samples (which was due to budget constraints). However, this will 
be addressed in a future study which will be conducted in a large healthcare organization 
of South Africa. Another limitation to the study is that total airborne dust measurements 
were not done as in the study by Kujala et al., 2002. 
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5.1 CONCLUSION 
 
 
The air sampling method and ELISA capture based assay used in this study offer the 
means of evaluating airborne allergen concentrations.  However, the kit is not sensitive at 
lower concentrations and further research would be required to pursue techniques that will 
increase the sensitivity of the kit, particularly for air samples. Alternatively, similar 
methods which are highly sensitive may be developed and the extraction methods be 
improved. The airborne latex concentrations are dependant on the type of products used, 
and perhaps the frequency of glove changes in busy clinics during the time of sampling. In 
addition, the type of set-up and the duration of sampling also determine the airborne latex 
concentration.  
 
The capture ELISA immunoassay offers a means to reliably assess the allergen content of 
various latex products and could eventually be used to set up exposure limits for other 
latex products thus reducing exposure to potentially allergenic proteins. The total protein 
content determination on the other hand is neither specific nor accurate enough to draw 
conclusions on the safety of latex products. However, because of the significant correlation 
yielded between the capture ELISA and total protein assay, the protein assay can be 
applied as a screening tool for estimating the allergenicity of latex products in the 
developing countries as it is more cost-effective.  It is evident from this study that NRL 
products containing allergenic levels high enough to cause latex allergy is still being used 
in the South African market.  The initiative to use non-powdered low protein latex gloves, 
if not synthetic products (non-latex) is therefore poorly supported. Hev b 3 which was 
found at high levels in dental dams should be considered in future aerosol measurements in 
dental settings.  
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